The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease

Vedolizumab is a humanized monoclonal antibody used to treat moderate-to-severe inflammatory bowel disease (IBD). The aim of the study was to assess the effectiveness of the induction of vedolizumab trough level in predicting short-term (week 14) clinical outcomes, and covariates that affect the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Anbarserry, Doaa, Mosli, Mahmoud, Qari, Yousef, Saadah, Omar, Bokhary, Rana, Esmat, Ahmed, Alsieni, Mohammed, Shaker, Ahmed, Elango, Ramu, Alharthi, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889342/
https://www.ncbi.nlm.nih.gov/pubmed/36720977
http://dx.doi.org/10.1038/s41598-023-28566-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889342/
https://www.ncbi.nlm.nih.gov/pubmed/36720977
http://dx.doi.org/10.1038/s41598-023-28566-4

Ejemplares similares